Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“ST7 overlapping transcript 3 conserved region 3” (ENSG00000278482) is formally classified as a miscellaneous non-coding RNA mapped to the ST7 locus. It is not a canonical therapeutic target and lacks a recognized protein product, defined molecular function, or associated pathway in current biomedical literature. Common database entries list it only as a non-coding RNA region (RFAM: RF02185), without known involvement in disease, drug action, or signaling mechanisms[3][5][7][9]. This entry should not be used as a classical molecular target for drug discovery or translational research. For structured information on receptor, enzyme, transporter, transcription factor, or other established protein targets, a different gene or protein identifier is required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST7 overlapping transcript 3 conserved region 3.